Literature DB >> 15009667

Identification of regulated genes during permanent focal cerebral ischaemia: characterization of the protein kinase 9b5/MARKL1/MARK4.

Armin Schneider1, Rico Laage, Oliver von Ahsen, Achim Fischer, Moritz Rossner, Sigrid Scheek, Sylvia Grünewald, Rohini Kuner, Daniela Weber, Carola Krüger, Bettina Klaussner, Bernhard Götz, Holger Hiemisch, Dieter Newrzella, Ana Martin-Villalba, Alfred Bach, Markus Schwaninger.   

Abstract

Cerebral ischaemia induces transcriptional changes in a number of pathophysiologically important genes. Here we have systematically studied gene expression changes after 90 min and 24 h of permanent focal ischaemia in the mouse by an advanced fragment display technique (restriction-mediated differential display). We identified 56 transcriptionally altered genes, many of which provide novel hints to ischaemic pathophysiology. Particularly interesting were two pro-apoptotic genes (Grim19 and Tdag51), whose role in cerebral ischaemia and neuronal cell death has not been recognized so far. Among the unknown sequences, we identified a gene that was rapidly and transiently up-regulated. The encoded protein displayed high homology to the MARK family of serine-threonine protein kinases and has recently been described as MARKL1/MARK4. Here we demonstrate that this protein is a functional protein kinase with the ability to specifically phosphorylate a cognate peptide substrate for the AMP-kinase family. Upon overexpression in heterologous cells, the functional wild-type protein, but not its kinase-dead mutant, led to decreased cell viability. We conclude that the up-regulation of this kinase during focal ischaemia may represent an interesting new target for pharmacological intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009667     DOI: 10.1046/j.1471-4159.2003.02228.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin.

Authors:  Dorthe Matenia; Bettina Griesshaber; Xiao-yu Li; Anja Thiessen; Cindy Johne; Jian Jiao; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  Mol Biol Cell       Date:  2005-07-12       Impact factor: 4.138

2.  A novel HSF1-mediated death pathway that is suppressed by heat shock proteins.

Authors:  Naoki Hayashida; Sachiye Inouye; Mitsuaki Fujimoto; Yasunori Tanaka; Hanae Izu; Eiichi Takaki; Hitoshi Ichikawa; Jaerang Rho; Akira Nakai
Journal:  EMBO J       Date:  2006-10-05       Impact factor: 11.598

3.  Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1.

Authors:  Ji-Wu Wang; Yuzuru Imai; Bingwei Lu
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

4.  Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated.

Authors:  Kanae Ando; Mikiko Oka; Yosuke Ohtake; Motoki Hayashishita; Sawako Shimizu; Shin-Ichi Hisanaga; Koichi M Iijima
Journal:  Biochem Biophys Res Commun       Date:  2016-08-09       Impact factor: 3.575

Review 5.  Regulation of microtubule (MT)-based cytoskeleton in the seminiferous epithelium during spermatogenesis.

Authors:  Elizabeth I Tang; Dolores D Mruk; C Yan Cheng
Journal:  Semin Cell Dev Biol       Date:  2016-01-11       Impact factor: 7.727

6.  Accurate balance of the polarity kinase MARK2/Par-1 is required for proper cortical neuronal migration.

Authors:  Tamar Sapir; Sivan Sapoznik; Talia Levy; Danit Finkelshtein; Anat Shmueli; Thomas Timm; Eva-Maria Mandelkow; Orly Reiner
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

7.  The IFN-beta and retinoic acid-induced cell death regulator GRIM-19 is upregulated during focal cerebral ischemia.

Authors:  Zara Mehrabian; Krish Chandrasekaran; Sudhakar Kalakonda; Tibor Kristian; Gary Fiskum; Dhananjaya V Kalvakolanu
Journal:  J Interferon Cytokine Res       Date:  2007-05       Impact factor: 2.607

8.  MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism.

Authors:  Xuan Li; Sarah Thome; Xiaodan Ma; Mamta Amrute-Nayak; Alison Finigan; Lauren Kitt; Leanne Masters; John R James; Yuguang Shi; Guoyu Meng; Ziad Mallat
Journal:  Nat Commun       Date:  2017-06-28       Impact factor: 14.919

9.  Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.

Authors:  Claudia Pitzer; Carola Krüger; Christian Plaas; Friederike Kirsch; Tanjew Dittgen; Ralph Müller; Rico Laage; Stefan Kastner; Stefanie Suess; Robert Spoelgen; Alexandre Henriques; Hannelore Ehrenreich; Wolf-Rüdiger Schäbitz; Alfred Bach; Armin Schneider
Journal:  Brain       Date:  2008-10-03       Impact factor: 13.501

10.  Mark4 promotes oxidative stress and inflammation via binding to PPARγ and activating NF-κB pathway in mice adipocytes.

Authors:  Zhenjiang Liu; Lu Gan; Yizhe Chen; Dan Luo; Zhenzhen Zhang; Weina Cao; Zhongjie Zhou; Xueting Lin; Chao Sun
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.